Related Experiment Video
Updated: Jun 18, 2026

Preparation of Virus-Enriched Inoculum for Oral Infection of Honey Bees (Apis mellifera)
Published on: August 26, 2020
Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review
Nike Walter1,2,3, Aaron Teja Bolte2, Mohammadali Khan Mirzaei3,4
1Department for Trauma Surgery, University Hospital Regensburg, Regensburg, Germany.
Abstract:
American foulbrood (AFB), caused by the spore-forming bacterium Paenibacillus larvae, is the most destructive bacterial brood disease of Apis mellifera. Control is challenging because endospores persist for decades and antibiotic use is restricted by regulations, resistance, and residue concerns. Bacteriophages have re-emerged as a species-specific, residue-free strategy for AFB prevention and treatment. A PRISMA-guided systematic review was conducted searching PubMed, Embase, and Web of Science using the terms (bacteriophage OR phage) AND (honeybee OR Apis mellifera). A total of 90 records were retrieved; after deduplication (19 removed), 71 titles and abstracts were screened. Eleven full texts were assessed for eligibility. Nine studies met inclusion criteria: three in adult bees or colonies, four in larvae, and two in vitro. Across studies, 27 P. larvae phages were characterized in vitro, 18 tested in larval assays, and nine evaluated at the hive level, mainly via oral delivery. In a controlled hive trial, a three-phage cocktail provided complete protection from natural AFB (100% protected vs. 80% infection in controls; p < 0.05) and enabled full recovery within 2 weeks, performing comparably to or better than prophylactic antibiotics. Larval studies generally showed significantly improved survival with prophylactic or therapeutic dosing, though efficacy varied by phage. A biodistribution study found limited indirect larval exposure after adult feeding (~32 PFU/larva at 24 h), indicating hive-mediated inactivation as a key translational barrier. One phage bound both vegetative cells and spores while retaining ~93% in-vitro infectivity. Overall, phage cocktails show strong proof-of-concept, with formulation, delivery, and rational cocktail design as key translational priorities.
Insights
Bacteriophages offer a promising, residue-free alternative for controlling American foulbrood (AFB) in honeybees. Phage cocktails demonstrated significant protection and recovery in hive trials, highlighting their potential as a sustainable bee disease management strategy.
Area of Science:
- Apiculture and Veterinary Entomology
- Microbiology and Virology
- Bacterial Disease Control in Honeybees
Background:
- American foulbrood (AFB), caused by *Paenibacillus larvae*, is a severe threat to *Apis mellifera* populations.
- Traditional control methods are limited by persistent endospores and regulatory restrictions on antibiotic use.
- Bacteriophages present a species-specific, residue-free alternative for AFB management.
Purpose of the Study:
- To systematically review the current state of bacteriophage research for American foulbrood prevention and treatment in honeybees.
- To evaluate the efficacy and translational potential of bacteriophage-based strategies for AFB control.
Main Methods:
- A PRISMA-guided systematic review of literature from PubMed, Embase, and Web of Science was performed.
- Studies involving bacteriophages targeting *Paenibacillus larvae* in *Apis mellifera* were included.
- Data synthesis covered *in vitro* characterization, larval assays, and hive-level evaluations, including controlled trials.
Main Results:
- Nine studies met inclusion criteria, evaluating 27 phages *in vitro*, 18 in larval assays, and nine at the hive level.
- A three-phage cocktail provided complete protection (100%) against natural AFB and facilitated recovery within two weeks in a controlled hive trial.
- Phage efficacy varied, with limited indirect larval exposure observed after adult feeding, suggesting hive-mediated inactivation as a barrier.
Conclusions:
- Bacteriophage cocktails demonstrate strong proof-of-concept for controlling American foulbrood in honeybees.
- Further research priorities include optimizing phage formulation, delivery methods, and rational cocktail design for practical application.
- Phage therapy represents a sustainable and residue-free strategy for bee disease management.

